Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices.

By E. Meites, A. Kempe, L. Markowitz. MMWR. Morbidity and mortality weekly report, 2016

812 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices (2019, background): “Dosing schedules, intervals, and definitions of persons considered adequately vaccinated have not changed (3).”
Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening (2018, background): “In October 2016, after FDA approval of a new dosing schedule for HPV vaccination, the Advisory Committee on Immunization Practices recommended a new 2-dose schedule for girls and boys who initiate the vaccination series at ages 9 through 14 years.(44) Late vaccination for those not vaccinated at the”